[Resistance to protease inhibitors].
Clotet
B
B
Unidad Infección VIH, Laboratorio de Retrovirología de la Fundación Irsi Caixa, Hospital Universitario Germans Trías i Pujol, Badalona.
Martínez-Picado
J
J
Arrizabalaga
J
J
Ruiz
L
L
D002219:Carbamates; D004352:Drug Resistance, Microbial / Q000235:genetics; D005663:Furans; D006678:HIV / Q000187:drug effects* / Q000235:genetics; D015658:HIV Infections / Q000188:drug therapy; D016333:HIV Protease / Q000235:genetics; D017320:HIV Protease Inhibitors / Q000494:pharmacology*; D006801:Humans; D019469:Indinavir / Q000494:pharmacology; D009154:Mutation; D019888:Nelfinavir / Q000494:pharmacology; D019438:Ritonavir / Q000494:pharmacology; D019258:Saquinavir / Q000494:pharmacology; D013449:Sulfonamides / Q000494:pharmacology
D002219:Carbamates; D005663:Furans; D017320:HIV Protease Inhibitors; D013449:Sulfonamides; C095108:amprenavir; D019469:Indinavir; D016333:HIV Protease; D019888:Nelfinavir; D019258:Saquinavir; D019438:Ritonavir